The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma
暂无分享,去创建一个
C. Nanni | S. Avnet | N. Baldini | N. Zini | M. Dominici | D. Heymann | G. Grisendi | Gemma Di Pompo | C. Errani | M. Columbaro | A. Longhi | A. Righi | D. Longo | Lorena Consolino | Silvia Lemma | F. Perut | L. Roncuzzi | Giulia Golinelli | Maria Veronica Lipreri | M. Cortini | G. Golinelli
[1] S. Avnet,et al. Acid Microenvironment in Bone Sarcomas , 2021, Cancers.
[2] R. Kalluri,et al. αSMA+ fibroblasts suppress Lgr5+ cancer stem cells and restrain colorectal cancer progression , 2021, Oncogene.
[3] R. Gillies. Cancer heterogeneity and metastasis: life at the edge , 2021, Clinical & Experimental Metastasis.
[4] M. Alonso-Alonso,et al. Extracellular Vesicles from Human Adipose-Derived Mesenchymal Stem Cells: A Review of Common Cargos , 2021, Stem Cell Reviews and Reports.
[5] B. Bordini,et al. C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases , 2021, International Orthopaedics.
[6] S. Avnet,et al. Exploring Metabolic Adaptations to the Acidic Microenvironment of Osteosarcoma Cells Unveils Sphingosine 1-Phosphate as a Valuable Therapeutic Target , 2021, Cancers.
[7] Yuanyuan Shi,et al. Mesenchymal stem cell-derived exosomal microRNA-136-5p inhibits chondrocyte degeneration in traumatic osteoarthritis by targeting ELF3 , 2020, Arthritis Research & Therapy.
[8] S. Shaabani,et al. Sarcoma treatment in the era of molecular medicine , 2020, EMBO molecular medicine.
[9] R. Hass. Role of MSC in the Tumor Microenvironment , 2020, Cancers.
[10] Jun-Miao Zhu,et al. Bone marrow‐derived mesenchymal stem cell‐derived exosomal microRNA‐208a promotes osteosarcoma cell proliferation, migration, and invasion , 2020, Journal of cellular physiology.
[11] Zhe Wang,et al. A risk signature‐based on metastasis‐associated genes to predict survival of patients with osteosarcoma , 2020, Journal of cellular biochemistry.
[12] Wook Kim,et al. Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model , 2019, PloS one.
[13] S. Avnet,et al. Photodynamic Surgery for Feline Injection-Site Sarcoma , 2019, BioMed Research International.
[14] K. Gilligan,et al. Role of Extracellular Vesicles (EVs) in Cell Stress Response and Resistance to Cancer Therapy , 2019, Cancers.
[15] Jing Xu,et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.
[16] Shaohui Zong,et al. miR-136-5p Regulates the Inflammatory Response by Targeting the IKKβ/NF-κB/A20 Pathway After Spinal Cord Injury , 2018, Cellular Physiology and Biochemistry.
[17] S. Avnet,et al. Validation of Suitable Housekeeping Genes for the Normalization of mRNA Expression for Studying Tumor Acidosis , 2018, International journal of molecular sciences.
[18] Y. Oike,et al. TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma , 2018, Oncogene.
[19] M. Karin,et al. NF-κB, inflammation, immunity and cancer: coming of age , 2018, Nature Reviews Immunology.
[20] M. Heymann,et al. Biology of Bone Sarcomas and New Therapeutic Developments , 2017, Calcified Tissue International.
[21] Shaohui Zong,et al. Molecular Mechanism of MiR-136-5p Targeting NF-κB/A20 in the IL-17-Mediated Inflammatory Response after Spinal Cord Injury , 2017, Cellular Physiology and Biochemistry.
[22] S. Avnet,et al. Mesenchymal stroma: Role in osteosarcoma progression. , 2017, Cancer letters.
[23] Hengxing Zhou,et al. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray , 2017, Molecular medicine reports.
[24] O. Feron,et al. Tumour acidosis: from the passenger to the driver's seat , 2017, Nature Reviews Cancer.
[25] S. Aime,et al. In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging. , 2017, International journal of oncology.
[26] R. Gillies,et al. Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma , 2017, Oncotarget.
[27] S. Avnet,et al. Therapeutic implications of tumor interstitial acidification. , 2017, Seminars in cancer biology.
[28] R. Gillies,et al. Cancer‐associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF‐κB activation , 2017, International journal of cancer.
[29] T. Lagerweij,et al. Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression , 2017, Clinical Cancer Research.
[30] Markus Schwaiger,et al. In Vivo Imaging of Tumor Metabolism and Acidosis by Combining PET and MRI-CEST pH Imaging. , 2016, Cancer research.
[31] S. Avnet,et al. Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance , 2016, Oncotarget.
[32] B. Heit,et al. Antimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus , 2015, Pathogens.
[33] S. Avnet,et al. Proton channels and exchangers in cancer. , 2015, Biochimica et biophysica acta.
[34] U. Schaible,et al. Macrophage defense mechanisms against intracellular bacteria , 2015, Immunological reviews.
[35] S. Avnet,et al. Impairment of Lysosomal Activity as a Therapeutic Modality Targeting Cancer Stem Cells of Embryonal Rhabdomyosarcoma Cell Line RD , 2014, PloS one.
[36] S. Avnet,et al. Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells , 2014, Oncotarget.
[37] Wenjie Zheng,et al. Effect of the cytokine levels in serum on osteosarcoma , 2014, Tumor Biology.
[38] Valentina Gori,et al. Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. , 2013, Biochimica et biophysica acta.
[39] Thomas E. Spencer,et al. Exosomal and Non-Exosomal Transport of Extra-Cellular microRNAs in Follicular Fluid: Implications for Bovine Oocyte Developmental Competence , 2013, PloS one.
[40] S. Avnet,et al. V-ATPase is a candidate therapeutic target for Ewing sarcoma. , 2013, Biochimica et biophysica acta.
[41] S. Avnet,et al. Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas. , 2013, International journal of oncology.
[42] Q. Fan,et al. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma. , 2012, Cancer letters.
[43] Enzo Terreno,et al. Iopamidol as a responsive MRI‐chemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T , 2011, Magnetic resonance in medicine.
[44] Rafael Sirera,et al. The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[45] M. Heymann,et al. Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence , 2010, PloS one.
[46] G. Rossi,et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. , 2010, Cancer research.
[47] M. Karin. NF-kappaB as a critical link between inflammation and cancer. , 2009, Cold Spring Harbor perspectives in biology.
[48] Gang Li,et al. Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. , 2009, Cancer letters.
[49] Frank Speleman,et al. A novel and universal method for microRNA RT-qPCR data normalization , 2009, Genome Biology.
[50] G. Bacci,et al. Primary bone osteosarcoma in the pediatric age: state of the art. , 2006, Cancer treatment reviews.
[51] J. Pouysségur,et al. Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.
[52] P. Rutkowski,et al. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis , 2003, Journal of surgical oncology.
[53] J. Allay,et al. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells. , 1999, Human gene therapy.
[54] D. Leeper,et al. Extracellular pH distribution in human tumours. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[55] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[56] G. Nordby,et al. Measurement of synovial fluid pH in normal and arthritic knees. , 1966, Arthritis and rheumatism.
[57] M. Truffi,et al. Fibroblasts in the Tumor Microenvironment. , 2020, Advances in experimental medicine and biology.
[58] C. Pressimone,et al. Mesenchymal Stem Cells in the Tumor Microenvironment. , 2020, Advances in experimental medicine and biology.
[59] O. Thews,et al. Acidosis differently modulates the inflammatory program in monocytes and macrophages. , 2016, Biochimica et biophysica acta.
[60] S. Avnet,et al. V-ATPase as an effective therapeutic target for sarcomas. , 2013, Experimental cell research.
[61] S. Ferrari,et al. Increased osteoclast activity is associated with aggressiveness of osteosarcoma. , 2008, International journal of oncology.